(19)
(11) EP 3 344 338 A1

(12)

(43) Date of publication:
11.07.2018 Bulletin 2018/28

(21) Application number: 16849494.6

(22) Date of filing: 21.09.2016
(51) International Patent Classification (IPC): 
A61P 29/00(2006.01)
A61K 9/14(2006.01)
A61P 11/00(2006.01)
(86) International application number:
PCT/US2016/052858
(87) International publication number:
WO 2017/053409 (30.03.2017 Gazette 2017/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 21.09.2015 US 201514860578

(71) Applicant: Prairie Pharmaceuticals, LLC
Bethesda, MD 20817 (US)

(72) Inventors:
  • LEE, Chang
    Bethesda, MD (US)
  • DU, Tao, Tom
    North Potomac, MD (US)

(74) Representative: J A Kemp 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) PULMONARY DELIVERY OF PROGESTOGEN